全新机制抑酸药物沃克(富马酸伏诺拉生片)获批进入中国( 二 )

[1] Sakurai Y, et al. Aliment pHarmacol Ther. 2015 Sep; 42(6):719-730.[2] Hunt RH, et al. Curr Treat Options Gastroenterol.2018 Dec;16(4):570-590[3] Martinucci I, et al. Expert Opin pHarmacother. 2017;18(11):1145-1152.[4] Xiao Y, Zhang S, Dai N, et al. Phase III, randomized, double-blind, multicenter study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis. Gut. 2019 Aug 13. pii: gutjnl-2019-318365. doi: 10.1136/gutjnl-2019-318365. [Epub ahead of print][5] Zou D, et al. Scand J Gastroenterol. 2011;46(2):133-41


推荐阅读